XSHG603987
Market cap415mUSD
Jan 09, Last price
6.98CNY
1D
-1.41%
1Q
3.41%
Jan 2017
-54.62%
IPO
-11.53%
Name
Shanghai Kindly Enterprise Development Group Co Ltd
Chart & Performance
Profile
Shanghai Kindly Enterprise Development Group Co.,LTD. produces and sells disposable medical polymer devices worldwide. It offers syringes, infusion sets, transfusion sets, medical tubes, needles and cannulas, and medical bags. The company also provides medical package materials, including PPPE composite films, medical packing films, sterilization indicator strips and Bowie Dick test packs, sterilization indicator tapes, medical wrapping papers, paper bags, and sterilization reels; and intervention accessories, such as guide wire, Y-connectors, inflation device, mainfold kit, pressure bandages, angiography syringes, stopcocks, sterile seldinger needle, introducer sets and tool kits, pressure transducer, extension tube, seldinger needles, hemostasis balloons, extension lines with needle free valves, pressure monitoring tubing products, and spine tool kits, as well as guiding, micro, and angiography catheters. In addition, it offers self-sealing pouches, tyverk reels, mini-spikes, PE extension tubes, suction catheter kits, irrigation kits, heparin caps, and umbilical cord clamps. Further, the company provides accessories, such as umbilical cord clamps, safety box, and stopcocks; and medical kits includes suction catheter and irrigation kits, and puncture sets. The company was founded in 1987 and is headquartered in Shanghai, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 2,452,598 -21.36% | 3,118,832 0.70% | |||||||
Cost of revenue | 2,024,361 | 2,550,952 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 428,236 | 567,879 | |||||||
NOPBT Margin | 17.46% | 18.21% | |||||||
Operating Taxes | 24,061 | 25,257 | |||||||
Tax Rate | 5.62% | 4.45% | |||||||
NOPAT | 404,175 | 542,622 | |||||||
Net income | 230,903 -25.93% | 311,736 -25.64% | |||||||
Dividends | (122,890) | (135,462) | |||||||
Dividend yield | 2.96% | 2.23% | |||||||
Proceeds from repurchase of equity | (160,013) | ||||||||
BB yield | 2.63% | ||||||||
Debt | |||||||||
Debt current | 701,855 | 715,898 | |||||||
Long-term debt | 89,963 | 80,758 | |||||||
Deferred revenue | 34,514 | 36,226 | |||||||
Other long-term liabilities | 35,597 | 18,617 | |||||||
Net debt | (165,568) | (40,445) | |||||||
Cash flow | |||||||||
Cash from operating activities | 450,072 | 461,736 | |||||||
CAPEX | (228,017) | ||||||||
Cash from investing activities | (195,720) | ||||||||
Cash from financing activities | (140,319) | ||||||||
FCF | 286,550 | 898,776 | |||||||
Balance | |||||||||
Cash | 510,536 | 422,974 | |||||||
Long term investments | 446,850 | 414,128 | |||||||
Excess cash | 834,757 | 681,160 | |||||||
Stockholders' equity | 2,225,887 | 2,038,210 | |||||||
Invested Capital | 2,758,824 | 2,665,993 | |||||||
ROIC | 14.90% | 18.79% | |||||||
ROCE | 11.85% | 16.86% | |||||||
EV | |||||||||
Common stock shares outstanding | 435,667 | 441,569 | |||||||
Price | 9.54 -30.77% | 13.78 -36.59% | |||||||
Market cap | 4,156,263 -31.69% | 6,084,821 -36.58% | |||||||
EV | 4,473,667 | 6,362,605 | |||||||
EBITDA | 592,941 | 725,419 | |||||||
EV/EBITDA | 7.54 | 8.77 | |||||||
Interest | 26,484 | 28,163 | |||||||
Interest/NOPBT | 6.18% | 4.96% |